Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) agreed to sign the Equity Transfer Agreement to acquire 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. for CNY 522.5 million on December 27, 2022. The transaction was approved by Zhejiang Huakang Pharmaceutical Co., Ltd. twenty-sixth meeting of the fifth board of directors. For the year ended, October 31, 2022, total asset is CNY 192.68 million and Owners equity is CNY 163.42 million.

Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077completed the acquisition of 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. on January 9, 2023.